title: Efficacy and safety of oral anticoagulants versus aspirin for patients with atrial fibrillation: a meta-analysis.
abstract: The purpose of this study was to perform a meta-analysis comparing the effectiveness and safety of anticoagulation to antiplatelet therapy for the prevention of thromboembolic events in patients with atrial fibrillation (AF). MEDLINE, Cochrane, EMBASE, and Google Scholar databases were searched for studies published through May 31, 2014. Randomized controlled trials comparing anticoagulants (warfarin) and antiplatelet therapy in patients with AF were included. The primary outcomes were the rates of stroke and systemic embolism. Secondary outcomes included the rates of hemorrhage/major bleeding and death. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Nine reports of 8 trials that enrolled 4363 patients (2169 patients received anticoagulation and 2194 antiplatelet therapy) were included. All of the studies compared adjusted-dose warfarin or with aspirin, and the majority of the patients were >70 years of age. Anticoagulants were titrated to an international normalized ratio (INR) of 2.0 to 4.5, and aspirin was administered at a dosage of 75 to 325 mg/d. Death occurred in 206 participants treated with an anticoagulant and 229 participants treated with antiplatelet therapy. There was no significant difference in the overall stroke rate between the groups (OR = 0.667, 95% CI 0.426-1.045, P = 0.08); however, patients with nonrheumatic AF (NRAF) treated with an anticoagulant had a lower risk of stroke (OR = 0.557, 95% CI 0.411-0.753, P < 0.001). Anticoagulants were associated with a lower risk of embolism (OR = 0.616, 95% CI = 0.392-0.966, P = 0.04), and this finding persisted in patients with NRAF (OR = 0.581, 95% CI 0.359-0.941, P = 0.03). No significant difference in the rate of hemorrhage/major bleeding was noted (OR = 1.497, 95% CI 0.730-3.070, P = 0.27), and this finding persisted on subgroup analysis. Anticoagulants appear to be more effective than aspirin in preventing embolisms in patients with AF, as the risk of bleeding is not increased.
authors: From the Cardiac Arrhythmia Center (J-TZ, K-PC, SZ), Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, Beijing 100037, China.
authors: Jing-Tao
authors: JT
authors: Zhang
authors: Ke-Ping
authors: KP
authors: Chen
authors: Shu
authors: S
authors: Zhang
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D002986:Clinical Trials as Topic; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000209:etiology / Q000517:prevention & control; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D001241:Aspirin
references: Lancet. 2007 Aug 11;370(9586):493-503
references: 17693178
references: Am J Geriatr Pharmacother. 2012 Feb;10(1):25-36.e2
references: 22226690
references: Lancet. 1993 Nov 20;342(8882):1255-62
references: 7901582
references: Lancet. 1994 Mar 19;343(8899):687-91
references: 7907677
references: J Heart Valve Dis. 2007 Nov;16(6):667-71
references: 18095518
references: Can J Cardiol. 2012 Mar-Apr;28(2):245.e17; author reply 245.e17-8
references: 22244772
references: Lancet. 2006 Jun 10;367(9526):1903-12
references: 16765759
references: Stroke. 2012 Dec;43(12):3291-7
references: 23033347
references: J Am Geriatr Soc. 2013 Oct;61(10):1798-803
references: 24083473
references: Front Physiol. 2014 Jan 24;5:15
references: 24478726
references: Am Heart J. 2006 Nov;152(5):967-73
references: 17070169
references: Stroke. 1991 Aug;22(8):983-8
references: 1866765
references: N Engl J Med. 2001 Nov 15;345(20):1444-51
references: 11794192
references: Circulation. 2008 Nov 11;118(20):2029-37
references: 18955670
references: Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):569-74
references: 22345595
references: Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Apr;34(4):295-8
references: 16776915
references: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006186
references: 17636831
references: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000187
references: 15494992
references: Thromb Res. 2011 Feb;127(2):91-9
references: 21172721
references: J Hypertens. 2007 Mar;25(3):551-6
references: 17278970
references: Lancet Neurol. 2007 Feb;6(2):115-24
references: 17239798
references: Expert Opin Pharmacother. 2011 Jul;12(10):1473-9
references: 21635195
references: Clin Cardiol. 2013 Jul;36(7):427-32
references: 23670894
references: Lancet. 1989 Jan 28;1(8631):175-9
references: 2563096
references: Int J Cardiol. 2013 Sep 1;167(5):1807-24
references: 23380698
references: Arq Bras Cardiol. 2010 Dec;95(6):749-55
references: 20976374
references: J Clin Invest. 2011 Aug;121(8):2955-68
references: 21804195
references: Stroke. 1997 May;28(5):1015-21
references: 9158644
references: Circulation. 2014 Dec 2;130(23):2071-104
references: 24682348
references: N Engl J Med. 2011 Sep 15;365(11):981-92
references: 21870978
references: Ann Intern Med. 2007 Oct 16;147(8):590-2
references: 17938402
references: J Mol Cell Cardiol. 2013 Nov;64:120-3
references: 24041536
references: Arch Intern Med. 1998 Jul 27;158(14):1513-21
references: 9679792
references: Clin J Am Soc Nephrol. 2011 Nov;6(11):2599-604
references: 21903982
references: J Am Med Dir Assoc. 2012 Jan;13(1):8-10
references: 21621470
references: Circulation. 2014 Feb 25;129(8):837-47
references: 24345399
references: Heart. 2008 Dec;94(12):1607-13
references: 18208828
references: BMJ. 1999 Oct 9;319(7215):958-64
references: 10514159
references: J Gen Intern Med. 2000 Jan;15(1):56-67
references: 10632835
references: Europace. 2014 Jan;16(1):6-14
references: 24084680
references: Age Ageing. 2007 Mar;36(2):151-6
references: 17175564
references: Arch Intern Med. 1996 Feb 26;156(4):409-16
references: 8607726